The pharmaceutical sector has been and remains a key strategic sector in Europe. The future of this sector is a crucial matter for the EU.

Today, the Commission launches a broad public debate on the future of pharmaceuticals for human use in the Community. All stakeholders dealing with medicines for human use are invited to participate. The Consultation Paper which forms the basis for the public consultation is available under documents. Contributions should be sent by e-mail before 12 October 2007. Details on the consultation process are outlined in the Consultation Paper.

Following this public debate, the Commission intends to address a Communication to the Council of the European Union and to the European Parliament on the future of the EU single market in pharmaceuticals for human use, outlining its vision and strategy for the sector, as well as concrete action items. The Communication will build on this public consultation and will outline how its outcome was taken into account.

Document MT version: Biex taċċessa l-informazzjoni f’waħda mill-lingwi disponibbli, jekk jogħġbok għażel wieħed mill-links li ġejjin.

Outcome of the consultation